INVO BioScience, Inc. (INVO) Financial Statements (2024 and earlier)

Company Profile

Business Address 5582 BROADCAST COURT
SARASOTA, FL 34240
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1122,188902861,9623,840
Cash and cash equivalents1122,188902861,9623,840
Receivables7510077715659
Inventory, net of allowances, customer advances and progress billings280271264280282295
Inventory280271264280282295
Other undisclosed current assets375251190305248228
Total current assets:8422,8106219422,5484,421
Noncurrent Assets
Operating lease, right-of-use asset4,0051,7501,8081,8661,9231,980
Property, plant and equipment659418437456473492
Long-term investments and receivables1,1321,1741,2381,2811,3481,494
Long-term investments1,1321,1741,2381,2811,3481,494
Intangible assets, net (including goodwill)   133133133
Goodwill      
Intangible assets, net (excluding goodwill)   133133133
Total noncurrent assets:5,7973,3413,4833,7363,8774,099
TOTAL ASSETS:6,6396,1514,1044,6786,4258,520
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,8451,8471,349690467462
Accrued liabilities1,2021,221946   
Other undisclosed accounts payable and accrued liabilities642627403690467462
Deferred revenue1614712099776
Debt   100   
Due to related parties663   
Other liabilities      
Other undisclosed current liabilities2,4632,5561,178873736616
Total current liabilities:4,4694,4503,4091,6611,2801,084
Noncurrent Liabilities
Long-term debt and lease obligation   1,7291,7871,845
Long-term debt, excluding current maturities      
Liabilities, other than long-term debt3,8751,6131,672111
Deferred income tax liabilities222111
Operating lease, liability3,8731,6111,6701,7291,7871,845
Business combination, contingent consideration, liability      
Total noncurrent liabilities:3,8751,6131,6721,7301,7891,846
Total liabilities:8,3446,0635,0813,3913,0682,930
Equity
Equity, attributable to parent(1,705)88(978)1,2873,3565,590
Common stock011111
Additional paid in capital52,86952,42148,80548,30347,82247,254
Accumulated deficit(54,575)(52,334)(49,784)(47,016)(44,467)(41,665)
Total equity:(1,705)88(978)1,2873,3565,590
TOTAL LIABILITIES AND EQUITY:6,6396,1514,1044,6786,4258,520

Income Statement (P&L) ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Revenues316348278235146163
Cost of revenue  (73)(79)(109)(78)(65)
Cost of goods and services sold  (61)(67)(98)(64)(58)
Gross profit:3162751991266898
Operating expenses(2,382)(2,582)(2,917)(2,652)(2,750)(2,799)
Operating loss:(2,066)(2,306)(2,718)(2,525)(2,682)(2,701)
Nonoperating expense(172)(244)(47)(24)(119)(73)
Interest and debt expense(175)(217)(56)(2)(0)(1)
Loss from continuing operations before equity method investments, income taxes:(2,413)(2,767)(2,821)(2,551)(2,801)(2,776)
Other undisclosed income from continuing operations before income taxes175 5620 
Loss from continuing operations before income taxes:(2,238)(2,767)(2,765)(2,550)(2,801)(2,776)
Income tax expense(3) (2) (1) 
Loss from continuing operations:(2,241)(2,767)(2,767)(2,550)(2,802)(2,776)
Loss before gain (loss) on sale of properties:(2,550)(2,802)(2,776)
Other undisclosed net income  217    
Net loss:(2,241)(2,551)(2,767)(2,550)(2,802)(2,776)
Other undisclosed net income attributable to parent      1
Net loss available to common stockholders, diluted:(2,241)(2,551)(2,767)(2,550)(2,802)(2,774)

Comprehensive Income ($ in thousands)

9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
12/31/2022
Q4
9/30/2022
Q3
6/30/2022
Q2
3/31/2022
Q1
Net loss:(2,241)(2,551)(2,767)(2,550)(2,802)(2,776)
Comprehensive loss, net of tax, attributable to parent:(2,241)(2,551)(2,767)(2,550)(2,802)(2,776)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: